Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib Phase 3 Study (Japan)
jRCT2080221378Phase 3Completed
- Start
- Feb 2011
- Modality
- Small Molecules
01
Overview
Phase 3 trial of regorafenib in cancer. Started Feb 2011; status: completed.
02
Drugs
regorafenib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221378.